Kaya Analyst Review May 2026

This Kaya analyst review for May 2026 covers the key data investors need for KAYA at its current price of Rs 168. Kaya (NSE: KAYA) is a skincare and hair clinic chain with a market capitalisation of approximately Rs 1,200 crore, operating clinics in India and the Middle East. The analyst consensus target of Rs 225 implies meaningful upside, and this Kaya analyst review examines technical levels, business performance, valuation, and key risks for KAYA through FY27.

Click Here – Get Free Investment Predictions

Kaya Company Snapshot May 2026

Kaya Skin Clinic operates 75 plus clinics offering dermatologist-supervised skin and hair treatments including laser hair removal, anti-ageing treatments, and acne management. Growing premium skincare demand is a tailwind. The table below summarises the key data referenced in this Kaya analyst review.

Parameter	Value
NSE Ticker	KAYA
Sector	Healthcare – Skin and Hair Clinics
CMP (May 2026)	Rs 168
52 Week High	Rs 295
52 Week Low	Rs 148
Market Cap	Rs 1,200 Crore
Trailing P/E	NAx
Analyst Consensus Target	Rs 225
Bull Case Target	Rs 280
Bear Case Target	Rs 148

Analyst Insight in This Kaya Analyst Review

Senior Research Analyst Ankit Jaiswal flags Kaya as a stock to watch in May 2026. At Rs 168, Ankit Jaiswal identifies key support in the Rs 150.96 to Rs 159.60 band and resistance near Rs 178.08. He suggests watching Kaya for a potential move toward Rs 225, subject to Healthcare – Skin and Hair Clinics sector momentum. Ankit Jaiswal’s view is one input in this Kaya analyst review and does not constitute a trade recommendation.

Technical Analysis in This Kaya Analyst Review

At Rs 168, KAYA is trading within its 52-week band of Rs 148 to Rs 295. The current position relative to the 52-week high and low is the first layer of technical context for any entry or exit decision. Momentum indicators including the 14-day RSI, MACD crossover, and volume trends are useful secondary signals to monitor alongside the Nifty 50 direction.

Near-term support is identified in the Rs 150.96 to Rs 159.60 band while resistance is seen in the Rs 178.08 to Rs 196.50 zone. A sustained move above Rs 178.08 could open the path toward the analyst consensus target of Rs 225 as identified in this Kaya analyst review.

Screen the best stocks on the Univest Screener.

Key Support and Resistance Levels

• Support Zone: Rs 150.96 to Rs 159.60 – investors tracking this Kaya analyst review should watch for stabilisation or a bounce in this range as a potential accumulation signal for KAYA.
• Resistance Zone: Rs 178.08 to Rs 196.50 – a sustained close above Rs 178.08 would be a positive breakout signal worth flagging in this Kaya analyst review.
• Medium-Term Target: The analyst consensus of Rs 225 represents the base-case upside scenario in this Kaya analyst review.

Business Segment Analysis

Skin Clinic Treatments (Core Revenue)

This is the primary revenue and margin driver for Kaya, directly supporting the earnings trajectory toward the consensus target of Rs 225.

Hair Clinic and Scalp Treatments

This segment adds scale and diversification to Kaya’s business model and is a meaningful EPS contributor through FY27 and FY28.

Skincare Products and Home Care Range

This represents the medium-term growth frontier for Kaya and a key re-rating catalyst for the stock over the next 12 to 24 months.

Valuation in This Kaya Analyst Review

At Rs 168, Kaya trades at a trailing P/E of NAx. This Kaya analyst review presents three scenarios: a bull case of Rs 280 on strong earnings delivery, a base case of Rs 225 at analyst consensus, and a bear case of Rs 148 if macro headwinds persist. Q1 FY27 results will be the first key checkpoint for this Kaya analyst review.

Scenario	Target Price	Key Condition
Bull Case	Rs 280	Strong earnings delivery and sector re-rating
Base Case (Consensus)	Rs 225	Moderate growth, analyst consensus estimate
Bear Case	Rs 148	Earnings miss or macro headwinds

Trade Outlook for Kaya

Based on the technical and fundamental analysis in this Kaya analyst review, investors might watch KAYA near the support zone of Rs 150.96 to Rs 159.60 for potential opportunities. A flag above Rs 178.08 could suggest improving momentum toward Rs 225. This article uses watch-and-flag language only and does not constitute a trade recommendation.

Key Risks for Kaya in FY27

A well-rounded Kaya analyst review must assess downside risks. Key risks for Kaya include a macro slowdown affecting Healthcare – Skin and Hair Clinics sector demand, input cost or regulatory headwinds compressing margins, continued FII selling from Indian equities, and earnings estimate downgrades if Q1 FY27 guidance disappoints. Market conditions may change rapidly. This analysis is not financial advice; investors should perform their own due diligence before investing in KAYA.

Download the Univest iOS App or the Univest Android App to get daily stock recommendations and expert research.

Conclusion: Kaya Analyst Review Verdict for 2026

This Kaya analyst review concludes that at Rs 168, KAYA offers a defined risk-reward with a consensus target of Rs 225. The 52-week range of Rs 148 to Rs 295 provides context on the current entry point. Use this Kaya analyst review as a research starting point and consult a SEBI-registered financial advisor before making any investment decisions on KAYA.

Frequently Asked Questions: Kaya Analyst Review 2026

What is the analyst target for Kaya in 2026?

The analyst consensus target is Rs 225, with a bull case of Rs 280 and a bear case of Rs 148. This Kaya analyst review recommends monitoring Q1 FY27 earnings for confirmation.

Is Kaya a good investment at Rs 168?

At Rs 168 with a P/E of NAx and a consensus target of Rs 225, this Kaya analyst review is constructive for medium to long-term investors in the Healthcare – Skin and Hair Clinics sector. Always consult a SEBI-registered advisor before investing.

What is Kaya’s 52-week high and low?

The 52-week high is Rs 295 and the 52-week low is Rs 148. At Rs 168, KAYA is positioned within this range as noted in this Kaya analyst review.

What are the key risks for Kaya?

Key risks include macro slowdown, input cost pressures, FII selling, and regulatory changes in the Healthcare – Skin and Hair Clinics sector as assessed in this Kaya analyst review.

Where can I track live data for Kaya?

Track Kaya’s live price and analyst targets on the Univest Screener alongside professional financial advice to complement this Kaya analyst review.

Investments in securities are subject to market risk. This content is for educational purposes only and does not constitute investment advice. Please consult a SEBI-registered financial advisor before making any investment decisions.